Table 2. Associations between TGFBI expression and clinicopathological factors of patients with ccRCC (based on TCGA-KIRC).
Characteristics | TGFBI expression | Chi-square/F | P | |
Low | High | |||
Stromal score | ||||
Low | 177 | 88 | 59.781 | <0.001 |
High | 88 | 177 | ||
Immune score | ||||
Low | 166 | 99 | 33.879 | <0.001 |
High | 99 | 166 | ||
Age | ||||
≤65 | 164 | 169 | 0.202 | 0.653 |
>65 | 101 | 96 | ||
Gender | ||||
Male | 148 | 196 | 19.085 | <0.001 |
Female | 117 | 69 | ||
Laterality | ||||
Left | 122 | 127 | 0.227 | 0.634 |
Right | 143 | 137 | ||
NA | 1 | |||
Grade | ||||
GX | 4 | 1 | 24.392 | <0.001 |
G1 | 10 | 4 | ||
G2 | 125 | 102 | ||
G3 | 103 | 119 | ||
G4 | 20 | 55 | ||
NA | 3 | 0 | ||
Stage | ||||
Stage I | 148 | 117 | 11.178 | 0.011 |
Stage II | 32 | 25 | ||
Stage III | 53 | 70 | ||
Stage IV | 32 | 51 | ||
Discrepancy | ||||
Cancer status | ||||
Tumor free | 194 | 160 | 14.169 | <0.001 |
With tumor | 59 | 101 | ||
NA | 12 | 4 |